. All data used in this study, including patient and treatment characteristics, were longitudinally abstracted from medical records by trained data managers at each of the 8 participating Member Institutions. Eligibility for the Outcomes Database for CRC
Search Results
Systemic Therapy for Advanced Appendiceal Adenocarcinoma: An Analysis From the NCCN Oncology Outcomes Database for Colorectal Cancer
Mohamedtaki A. Tejani, Anna ter Veer, Dana Milne, Rebecca Ottesen, Tanios Bekaii-Saab, Al B. Benson III, Deborah Schrag, Stephen Shibata, John Skibber, Martin Weiser, Neal Wilkinson, and Steven J. Cohen
Treatment Trends and Clinical Outcomes of Left-Sided RAS/RAF Wild-Type Metastatic Colorectal Cancer in the United States
Christopher Nevala-Plagemann, Siddharth Iyengar, Andrew D. Trunk, Lisa Pappas, Benjamin Haaland, and Ignacio Garrido-Laguna
Guidelines; Version 2.2021) do not specify a preferred chemotherapy plus targeted therapy combination for the up-front management of fit patients with left-sided RAS/RAF WT mCRC. 10 Clearly there is a need to identify patient or tumor characteristics that
Use and Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer: A Population-Based Study
Christopher M. Booth, Sulaiman Nanji, Xuejiao Wei, Yingwei Peng, James J. Biagi, Timothy P. Hanna, Monika K. Krzyzanowska, and William J. Mackillop
16 weeks after surgery. Characteristics of the study population are shown in Table 1 . The median age was 70 years and 52% were male. Use of ACT ACT was delivered to 66% (1,861/2,801) of the study population. Use rates remained stable
Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium Study
Quisette P. Janssen, Jacob L. van Dam, Laura R. Prakash, Deesje Doppenberg, Christopher H. Crane, Casper H.J. van Eijck, Susannah G. Ellsworth, William R. Jarnagin, Eileen M. O’Reilly, Alessandro Paniccia, Marsha Reyngold, Marc G. Besselink, Matthew H.G. Katz, Ching-Wei D. Tzeng, Amer H. Zureikat, Bas Groot Koerkamp, Alice C. Wei, and for the Trans-Atlantic Pancreatic Surgery (TAPS) Consortium
with concurrent chemotherapy) or stereotactic body RT (SBRT) regimens of ≥5 Gy per fraction in 5 fractions. Data Collection and Definitions Prespecified data on patient demographics, tumor characteristics, treatment details, and clinical and
Impact of Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients With Essential Thrombocythemia
Nikolai A. Podoltsev, Mengxin Zhu, Amer M. Zeidan, Rong Wang, Xiaoyi Wang, Amy J. Davidoff, Scott F. Huntington, Smith Giri, Steven D. Gore, and Xiaomei Ma
sociodemographic characteristics: age at diagnosis, sex, race, and Medicare Part D low-income subsidy, a marker for reduced out-of-pocket cost sharing and lower socioeconomic status. Receipt of influenza vaccination in the 12 months before ET diagnosis was included
Effect of Yoga and Mediational Influence of Fatigue on Walking, Physical Activity, and Quality of Life Among Cancer Survivors
Po-Ju Lin, Brian J. Altman, Nikesha J. Gilmore, Kah Poh Loh, Richard F. Dunne, Javier Bautista, Chunkit Fung, Michelle C. Janelsins, Luke J. Peppone, Marianne K. Melnik, Kim O. Gococo, Michael J. Messino, and Karen M. Mustian
demographic data and characteristics were examined with 2-tailed t tests for continuous variables and chi-square tests for categorical variables. Within-group differences in CRF’s interference with walking, PA, and QoL were assessed using 2-tailed t tests
Social Determinants of Health and Racial Disparities in Cardiac Events in Breast Cancer
Nickolas Stabellini, Mantas Dmukauskas, Marcio S. Bittencourt, Jennifer Cullen, Amie J. Barda, Justin X. Moore, Susan Dent, Husam Abdel-Qadir, Aniket A. Kawatkar, Ambarish Pandey, John Shanahan, Jill S. Barnholtz-Sloan, Kristin A. Waite, Alberto J. Montero, and Avirup Guha
-fib was included in our MACE definition because it is a commonly unaccounted event in patients with cancer. 32 Covariates Demographics, risk factors, tumor characteristics, and treatment data were obtained for all eligible patients. Demographic
Comparison of Mismatch Repair Status Between Primary and Matched Metastatic Sites in Patients With Colorectal Cancer
Wen-Zhuo He, Wan-Ming Hu, Fang Wang, Yu-Ming Rong, Lin Yang, Qian-Kun Xie, Yuan-Zhong Yang, Chang Jiang, Hui-Juan Qiu, Jia-Bin Lu, Bei Zhang, Pei-Rong Ding, Xiao-Jun Xia, Jian-Yong Shao, and Liang-Ping Xia
selection flowchart is summarized in supplemental eFigure 1 . Statistical Analysis All statistical analyses were performed using SPSS Statistics, version 13.0 (SPSS Inc). Frequencies and descriptive statistics were used to report patient characteristics and
Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer Database
Johannes Uhlig, Michael Cecchini, Amar Sheth, Stacey Stein, Jill Lacy, and Hyun S. Kim
KRAS wild-type). Table 1. Patient and Tumor Characteristics According to Microsatellite Status Table 2. Patient and Tumor Characteristics According to KRAS Status CRC Mutation Status: Impact on OS and Interaction With Tumor Location For survival
Pilot Randomized Trial of a Transdisciplinary Geriatric and Palliative Care Intervention for Older Adults With Cancer
Ryan D. Nipp, Brandon Temel, Charn-Xin Fuh, Paul Kay, Sophia Landay, Daniel Lage, Esteban Franco-Garcia, Erin Scott, Erin Stevens, Terrence O’Malley, Supriya Mohile, William Dale, Lara Traeger, Ardeshir Z. Hashmi, Vicki Jackson, Joseph A. Greer, Areej El-Jawahri, and Jennifer S. Temel
. Study Measures Sociodemographic and Clinical Characteristics Participants completed baseline study measures before randomization, and were asked to self-report their sex, race, relationship status, employment status, education level, annual income, and